Decay-accelerating factor expression in the rat kidney is restricted to the apical surface of podocytes

Kidney International

Volumn 62, Issue 6, 2002, Pages 2010-2021

  Bao, Lihua ^a,b,c,d   Spiller, Brad ^a,b,c,d   St John, Patricia L ^a,b,c,d   Haas, Mark ^a,b,c,d   Hack, Bradley K ^a,b,c,d   Ren, Guohui ^a,b,c,d   Cunningham, Patrick N ^a,b,c,d   Doshi, Mona ^a,b,c,d   Abrahamson, Dale R ^a,b,c,d   Morgan, B Paul ^a,b,c,d   Quigg, Richard J ^a,b,c,d  

^a UNIVERSITY OF CHICAGO   (United States)

^b CARDIFF UNIVERSITY   (United Kingdom)

^c UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Complement regulator; Glomerular epithelial cells; Heymann nephritis; Proteinuria; Puromycin aminonucleoside nephrosis; Renal injury

Indexed keywords

CD59 ANTIGEN; DECAY ACCELERATING FACTOR; IMMUNOGLOBULIN F(AB')2 FRAGMENT; IMMUNOGLOBULIN G ANTIBODY; MEGALIN; NEUTRALIZING ANTIBODY; PUROMYCIN AMINONUCLEOSIDE; ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CULTURE; CELL SURFACE; COMPLEMENT ACTIVATION; CONTROLLED STUDY; GLOMERULUS EPITHELIUM; IMMUNOELECTRON MICROSCOPY; IN VIVO STUDY; KIDNEY FAILURE; MALE; NONHUMAN; PODOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEINURIA; RAT; ANIMAL; CELL POLARITY; CHEMISTRY; CYTOLOGY; EPITHELIUM CELL; ERYTHROCYTE; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOLOGY; MESANGIUM; NEPHROSIS; PHYSIOLOGY; SPRAGUE DAWLEY RAT; ULTRASTRUCTURE;

ANIMALS; ANTIBODIES; ANTIGENS, CD55; CELL POLARITY; CELLS, CULTURED; COMPLEMENT ACTIVATION; EPITHELIAL CELLS; ERYTHROCYTES; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GLOMERULAR MESANGIUM; MALE; MICROSCOPY, IMMUNOELECTRON; NEPHROSIS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 18744378822     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2002.t01-1-00652.x     Document Type: Article

References (71)

1. Liszewski MK, Atkinson JP: The complement system (chapt 26), in Fundamental Immunology (3rd ed), edited by Paul WE, New York, Raven Press, 1993, pp 917-939
2. Walport MJ: Advances in immunology: Complement (first of two parts). N Engl J Med 344:1058-1066, 2001
3. Nicholson-Weller A, Halperin JA: Membrane signaling by complement C5b-9, the membrane attack complex. Immunol Res 12: 244-257, 1993
4. Liszewski MK, Farries TC, Lublin DM, et al: Control of the complement system. Adv Immunol 61:201-283, 1996
5. Campbell RD, Law SKA, Reid KBM, et al: Structure, organization, and regulation of the complement genes. Ann Rev Immunol 6:161-195, 1988
6. Foley S, Li B, Dehoff M, et al: Mouse Crry/p65 is a regulator of the alternative pathway of complement activation. Eur J Immunol 23:1381-1384, 1993
7. Kim Y-U, Kinoshita T, Molina H, et al: Mouse complement regulatory protein Crry/p65 uses the specific mechanisms of both human decay-accelerating factor and membrane cofactor protein. J Exp Med 181:151-159, 1995
8. Couser WG: Pathogenesis of glomerular damage in glomerulo-nephritis. Nephrol Dial Transplant 13(Suppl 1):10-15, 1998
9. Cybulsky AV, Foster MH, Salant DJ, Quigg RJ: Immunologic mechanisms of glomerular disease, in The Kidney: Physiology and Pathophysiology (3rd ed), edited by Seldin DW, Giebisch G, Philadelphia, Lippincott-Raven, 2000, pp 2645-2697
10. Kerjaschki D, Neale TJ: Molecular mechanisms of glomerular injury in rat experimental membranous nephropathy (Heymann nephritis). J Am Soc Nephrol 7:2518-2526, 1996
11. Kerjaschki D, Miettinen A, Farquhar MG: Initial events in the formation of immune deposits in passive Heymann nephritis. gp330-anti-gp330 immune complexes form in epithelial coated pits and rapidly become attached to the glomerular basement membrane. J Exp Med 166:109-128, 1987
12. Makker SP, Singh AK: Characterization of the antigen (gp600) of Heymann nephritis. Lab Invest 50:287-293, 1984
13. Quigg RJ, Abrahamson DR, Cybulsky AV, et al: Studies with antibodies to cultured rat glomerular epithelial cells: Subepithe-lial immune deposit formation after in vivo injection. Am J Pathol 134:1125-1133, 1989
14. Salant DJ, Quigg RJ, Cybulsky AV: Heymann nephritis: Mechanisms of renal injury. Kidney Int 35:976-984, 1989
15. Cybulsky AV, Quigg RJ, Salant DJ: Role of the complement membrane attack complex in glomerular injury, (chapt 3), in Contemporary Issues in Nephrology. Immunopathology of Renal Disease (18th ed), edited by Wilson CB, Brenner BM, Stein JH, New York, Churchill Livingstone, 1988, pp 57-86
16. Salant DJ, Belok S, Madaio MP, et al: A new role for complement in experimental membranous nephropathy in rats. J Clin Invest 66:1339-1350, 1980
17. Salant DJ, Darby C, Couser WG: Experimental membranous glomerulonephritis in rats. Quantitative studies of glomerular immune deposit formation in isolated glomeruli and whole animals. J Clin Invest 66:71-81, 1980
18. Somlo S, Mundel P: Getting a foothold in nephrotic syndrome. Nat Genet 24:333-335, 2000
19. Ryan GB, Karnovsky MJ: An ultrastructural study of the mechanisms of proteinuria in aminonucleoside nephrosis. Kidney Int 8:219-232, 1975
20. Fishman JA, Karnovsky MJ: Effects of the aminonucleoside of puromycin on glomerular epithelial cells in vitro. Am J Pathol 118:398-407, 1985
21. Nangaku M: Complement regulatory proteins in glomerular diseases. Kidney Int 54:1419-1428, 1998
22. Rushmere NK, Van den Berg CW, Harrison RA, et al: Molecular cloning of the rat analogue of human CD59: Structural comparison with human CD59 and identification of a putative active site. Biochem J 304:595-601, 1994
23. Ichida S, Yuzawa Y, Okada H, et al: Localization of the complement regulatory proteins in the normal human kidney. Kidney Int 46:89-96, 1994
24. Nakanishi I, Moutabarrik A, Hara T, et al: Identification and characterization of membrane cofactor protein (CD46) in the human kidneys. Eur J Immunol 24:1529-1535, 1994
25. Quigg RJ, Nicholson-Weller A, Cybulsky AV, et al: Decay accelerating factor regulates complement activation on glomerular epithelial cells. J Immunol 142:877-882, 1989
26. Quigg RJ, Morgan BP, Holers VM, et al: Complement regulation in the rat glomerulus: Crry and CD59 regulate complement in lomerular mesangial and endothelial cells. Kidney Int 48:412-421, 1995
27. Quigg RJ, Holers VM, Morgan BP, et al: Crry and CD59 regulate complement in rat glomerular epithelial cells and are inhibited by the nephritogenic antibody of passive Heymann nephritis. J Immunol 154:3437-3443, 1995
28. Schiller B, He C, Salant DJ, et al: Inhibition of complement regulation is key to the pathogenesis of Heymann nephritis. J Exp Med 188:1353-1358, 1998
29. Spiller OB, Hanna SM, Morgan BP: Tissue distribution of the rat analogue of decay accelerating factor. Immunology 97:374-384, 1999
30. Hinchliffe SJ, Spiller OB, Rushmere NK, et al: Molecular cloning and functional characterization of the rat analogue of human decay-accelerating factor. J Immunol 161:5695-5703, 1998
31. Cunningham PN, Hack BK, Ren G, et al: Glomerular complement regulation is overwhelmed in passive Heymann nephritis. Kidney Int 60:900-909, 2001
32. Mendrick DL, Chung DC, Rennke HG: Heymann antigen GP330 demonstrates affinity for fibronectin, laminin, and type I collagen and mediates rat proximal tubule epithelial cell adherence to such matrices in vitro. Exp Cell Res 188:23-35, 1990
33. Hughes TR, Piddlesden SJ, Williams JD, et al: Isolation and characterization of a membrane protein from rat erythrocytes which inhibits lysis by the membrane attack complex of rat complement. Biochem J 284:169-176, 1992
34. Holt DS, Botto M, Bygrave AE, et al: Targeted deletion of the CD59 gene causes spontaneous intravascular hemolysis and hemoglobinuria. Blood 98:442-449, 2001
35. Quigg RJ, Cybulsky AV, Salant DJ: Effect of nephritogenic antibody on complement regulation in cultured rat glomerular epithelial cells. J Immunol 147:838-845, 1991
36. Salant DJ, Madaio MP, Adler S, et al: Altered glomerular permeability induced by F(ab′)2 and Fab′ antibodies to rat renal tubular epithelial antigen. Kidney Int 21:36-43, 1982
37. Levidiotis V, Kanellis J, Ierino FL, et al: Increased expression of heparanase in puromycin aminonucleoside nephrosis. Kidney Int 60:1287-1296, 2001
38. Quigg RJ, Lim A, Haas M, et al: Immune complex glomerulonephritis in C4- and C3-deficient mice. Kidney Int 53:320-330, 1998
39. Nomura A, Morita Y, Maruyama S, et al: Role of complement in acute tubulointerstitial injury of rats with aminonucleoside nephrosis. Am J Pathol 151:539-547, 1997
40. Schulze M, Pruchno CJ, Burns M, et al: Glomerular C3c localization indicates ongoing immune deposit formation and complement activation in experimental glomerulonephritis. Am J Pathol 142:179-187, 1993
41. Nicholson-Weller A, March JP, Rosenfeld SI, et al: Affected erythrocytes of patients with paroxysmal nocturnal hemoglobinuria are deficient in the complement regulatory protein, decay accelerating factor. Proc Natl Acad Sci USA 80:5066-5070, 1983
42. Sun X, Funk CD, Deng C, et al: Role of decay-accelerating factor in regulating complement activation on the erythrocyte surface as revealed by gene targeting. Proc Natl Acad Sci USA 96:628-633, 1999
43. Nicholson-Weller A, Burge J, Fearon DT, et al: Isolation of a human erythrocyte membrane glycoprotein with decay-accelerating activity for C3 convertases of the complement system. J Immunol 129:184-189, 1982
44. Nicholson-Weller A, Burge J, Austen KF: Purification from guinea pig erythrocyte stroma of a decay-accelerating factor for the classical C3 convertase, C4b,2a. J Immunol 127:2035-2039, 1981
45. Rey-Campos J, Rubinstein P, Rodriguez de Cordoba S: A physical map of the human regulator of complement activation gene cluster linking the complement genes CR1, CR2, DAF, and C4BP. J Exp Med 167:664-669, 1988
46. Hourcade D, Holers VM, Atkinson JP: The regulators of complement activation (RCA) gene cluster. Adv Immunol 45:381-416, 1989
47. Kingsmore SF, Vik DP, Kurtz CB, et al: Genetic organization of complement receptor-related genes in the mouse. J Exp Med 169:1479-1484, 1989
48. Spicer AP, Seldin MF, Gendler SJ: Molecular cloning and chromosomal localization of the mouse decay-accelerating factor genes. J Immunol 155:3079-3091, 1995
49. Kurtz CB, O'Toole E, Christensen SM, et al: The murine complement receptor gene family. IV. Alternative splicing of Cr2 gene transcripts predicts two distinct gene products that share homologous domains with both human CR2 and CR1. J Immunol 144:3581-3591, 1990
50. Molina H, Kinoshita T, Inoue K, et al: A molecular and immunochemical characterization of mouse CR2. Evidence for a single gene model of mouse complement receptors 1 and 2. J Immunol 145:2974-2983, 1990
51. Paul MS, Aegerter M, O'Brien SE, et al: The murine complement receptor gene family. I. Analysis of mCRY gene products and their homology to human CR1. J Immunol 142:582-589, 1989
52. Takizawa H, Okada N, Okada H: Complement inhibitor of rat cell membrane resembling mouse Crry/p65. J Immunol 152:3032-3038, 1994
53. Song WC, Deng C, Raszmann K, et al: Mouse decay-accelerating factor: Selective and tissue-specific induction by estrogen of the gene encoding the glycosylphosphatidylinositol-anchored form. J Immunol 157:4166-4172, 1996
54. Mead R, Hinchliffe SJ, Morgan BP: Molecular cloning, expression and characterization of the rat analogue of human membrane cofactor protein (MCP/CD46). Immunology 98:137-143, 1999
55. Miwa T, Nonaka M, Okada N, et al: Molecular cloning of rat and mouse membrane cofactor protein (MCP, CD46): Preferential expression in testis and close linkage between the mouse Mcp and Cr2 genes on distal chromosome 1. Immunogenetics 48:363-371, 1998
56. Nicholson-weller A, Wang C: Structure and function of decay accelerating factor CD55. J Lab Clin Med 123:485-491, 1994
57. Walter EI, Ratnoff WD, Long KE, et al: Effect of glycoinositolphospholipid anchor lipid groups on functional properties of decay-accelerating factor protein in cells. J Biol Chem 267:1245-1252, 1992
58. Medof ME, Walter EI, Rutgers JL, et al: Identification of the complement decay-accelerating factor (DAF) on epithelium and glandular cells and in body fluids. J Exp Med 165:848-864, 1987
59. Cosio FG, Sedmak DD, Mahan JD, et al: Localization of decay accelerating factor in normal and diseased kidneys. Kidney Int 36:100-107, 1989
60. Arora M, Arora R, Tiwari SC, et al: Expression of complement regulatory proteins in diffuse proliferative glomerulonephritis. Lupus 9:127-131, 2000
61. Abe K, Miyazaki M, Koji T, et al: Expression of decay accelerating factor mRNA and complement C3 mRNA in human diseased kidney. Kidney Int 54:120-130, 1998
62. Shibata T, Cosio FG, Birmingham DJ: Complement activation induces the expression of decay-accelerating factor on human mesangial cells. J Immunol 147:3901-3908, 1991
63. Lin F, Fukuoka Y, Spicer A, et al: Tissue distribution of products of the mouse decay-accelerating factor (DAF) genes. Exploitation of a Daf1 knock-out mouse and site-specific monoclonal antibodies. Immunology 104:215-225, 2001
64. Sogabe H, Nangaku M, Ishibashi Y, et al: Increased susceptibility of decay-accelerating factor deficient mice to anti-glomerular basement membrane glomerulonephritis. J Immunol 167:2791-2797, 2001
65. Lin F, Emancipator SN, Salant DJ, et al: Decay-accelerating factor confers protection against complement-mediated podocyte injury in acute nephrotoxic nephritis. Lab Invest 82:563-569, 2002
66. Camussi G, Brentjens JR, Noble B, et al: Antibody-induced redistribution of Heymann antigen on the surface of cultured glomerular visceral epithelial cells: Possible role in the pathogenesis of Heymann glomerulonephritis. J Immunol 135:2409-2416, 1985
67. Matsuo S, Ichida S, Takizawa H, et al: In vivo effects of monoclonal autibodies that functionally inhibit complement regulatory proteins in rats. J Exp Med 180:1619-1627, 1994
68. Hori Y, Yamada K, Hanafusa N, et al: Crry, a complement regulatory protein, modulates renal interstitial disease induced by proteinuria. Kidney Int 56:2096-2106, 1999
69. Ratnoff WD, Knez JJ, Prince GM, et al: Structural properties of the glycoplasmanylinositol anchor phospholipid of the complement membrane attack complex inhibitor CD59. Clin Exp Immunol 87: 415-421, 1992
70. Brown DA, Crise B, Rose JK: Mechanism of membrane anchoring affects polarized expression of two proteins in MDCK cells. Science 245:1499-1501, 1989
71. Le Gall AH, Yeaman C, Muesch A, et al: Epithelial cell polarity: New perspectives. Semin Nephrol 15:272-284, 1995